Targeting cholesterol metabolism: a core regulator of tumor-associated macrophage plasticity and immunotherapy response
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026
DOI: 10.1016/j.bbcan.2026.189588 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Danyang Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chongqing University, Chongqing 400030, China. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Cholesterol, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: Chongqing University, Science-Health Joint Medical Scientific Research Project of Chongqing, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs) are one of the main immunosuppressive components in the tumor microenvironment (TME). Growing evidence indicates that their functional state is closely related to metabolic signaling, with cholesterol metabolism dysregulation receiving increasing attention. Abnormal cholesterol metabolism alters membrane lipid composition and signaling pathways, resulting in impaired antigen presentation, upregulation of immune checkpoint molecules, and persistent immunosuppression, thereby facilitating tumor immune evasion and metastasis. The imbalance in cholesterol uptake, esterification, and efflux within TAMs has emerged as a 'metabolic checkpoint' that influences their plasticity between pro-tumoral and anti-tumoral states. In this review, we systematically summarize current research progress on the mechanisms of these processes and discuss how cholesterol metabolism dysregulation reshapes the phenotype of TAMs. We further highlight current therapeutic strategies targeting cholesterol metabolism and the challenges that impede their clinical translation. Finally, we outline emerging advancements in nanomedicine, spatial multi-omics, and artificial intelligence, which may facilitate more precise metabolic reprogramming of TAMs in future immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Chongqing University, Chongqing 400030, China.
- School of Medicine, Chongqing University, Chongqing 400030, China; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China; Key Laboratory of Chongqing Education Commission of China…
Förderung
- Chongqing University
- Science-Health Joint Medical Scientific Research Project of Chongqing
- National Natural Science Foundation of China
Zitieren
APA
Li, D., Wu, L., & Li, Y. (2026). Targeting cholesterol metabolism: a core regulator of tumor-associated macrophage plasticity and immunotherapy response. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189588
Vancouver
Li D, Wu L, Li Y. Targeting cholesterol metabolism: a core regulator of tumor-associated macrophage plasticity and immunotherapy response. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189588
BibTeX
@article{Li2026,
author = {Li, Danyang and Wu, Lei and Li, Yongsheng},
title = {Targeting cholesterol metabolism: a core regulator of tumor-associated macrophage plasticity and immunotherapy response},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
doi = {10.1016/j.bbcan.2026.189588}
}
EUVIMED